Toxicity of lunar dust 1 2 Dag Linnarsson 1 , James Carpenter 2 , Bice Fubini 3 , Per Gerde 4,5 , Lars L. Karlsson 6 , 3 David J. Loftus 7 , G. Kim Prisk 8 , Urs Staufer 9 , Erin M. Tranfield 10 , and Wim van 4 Westrenen 11,* 5 6 1 Section of Environmental Physiology, Department of Physiology and Pharmacology, 7 Karolinska Institutet, Nanna Svartz v. 2, 171 77 Stockholm, Sweden, e-mail 8 [email protected]9 2 European Space Agency ESTEC, HME-HFR, Keplerlaan 1, 2200 AG, Noordwijk, 10 The Netherlands, e-mail [email protected]11 3 Department of Chemistry and Interdepartmental Center "G. Scansetti" for Studies on 12 Asbestos and other Toxic Particulates, University of Torino, Via P. Giuria 7,10125 13 Torino, Italy, e-mail [email protected]14 4 Division of Physiology, The National Institute of Environmental Medicine, 15 Karolinska Institutet, IMM, Box 287, 171 77 Stockholm, Sweden, e-mail 16 [email protected]17 5 Inhalation Sciences Sweden AB, Scheeles väg 1, 171 77 Stockholm, Sweden 18 6 Section of Environmental Physiology, Department of Physiology and Pharmacology, 19 Karolinska Institutet, Nanna Svartz v. 2, 171 77 Stockholm, Sweden, e-mail 20 [email protected]21 7 Space Biosciences Division, NASA Ames Research Center, Mail Stop 239-11, 22 Moffett Field, CA 94301, USA, e-mail [email protected]23 8 Departments of Medicine and Radiology, University of California, San Diego, 9500 24 Gilman Drive, La Jolla, CA 92093-0852, USA, e-mail [email protected]25
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Toxicity of lunar dust 1
2
Dag Linnarsson1, James Carpenter2, Bice Fubini3, Per Gerde4,5, Lars L. Karlsson6, 3
David J. Loftus7, G. Kim Prisk8, Urs Staufer9, Erin M. Tranfield10, and Wim van 4
Westrenen11,* 5
6
1Section of Environmental Physiology, Department of Physiology and Pharmacology, 7
Karolinska Institutet, Nanna Svartz v. 2, 171 77 Stockholm, Sweden, e-mail 8
Of these techniques only the analysis of exhaled nitric oxide is a standardized 678
technique used in clinical practice. Breath condensate and hydrocarbons are both 679
promising techniques but need further development. Additionally, new detection 680
methods and improved analytical techniques of completely novel and potentially more 681
precise markers of airway inflammation might be developed in the future. 682
7.2. Exhaled nitric oxide (NO) 683
The potential of NO as a marker of airway disease became apparent when 684
Gustafsson et al. (1991) found endogenous NO in the exhalate from both animals and 685
humans. In addition, Alving et al. (1993) and Persson et al. (1994) found increased 686
levels of exhaled NO in asthmatics with ongoing airway inflammation. Normal 687
exhaled NO levels are in the range of 10-35 parts per billion (ppb) in adults, and 688
around 5-25 ppb in children (Taylor et al., 2006). For asthma patients not adequately 689
treated with anti-inflammatory medication, exhaled NO levels are up to 70-100 ppb 690
and sometimes even higher. Exhaled NO is now used as a diagnostic tool in the 691
monitoring of asthma patients on Earth. 692
Naturally occurring enzymatic processes produce NO from the amino acid L-693
arginine and oxygen by the enzyme nitric oxide synthase (NOS). There are three 694
different known isoforms of NOS; two constitutive and one inducible (iNOS). The 695
constitutive NOS, i.e., neuronal NOS (nNOS) and endothelial NOS (eNOS), are 696
strictly Ca2+-dependent, whereas iNOS is dependent on gene expression regulation. 697
Potential sources of exhaled NO include the nasal epithelium (Lundberg et al., 698
1995), the airway epithelium (Asano et al., 1994), the alveolar epithelium (Asano et 699
al., 1994), the vascular endothelium (Ignarro et al., 1987), and the blood (Pawloski et 700
al., 2001). NO enters the airway lumen by gas diffusion driven by a concentration 701
gradient. All three isoforms of the NOS enzymes are present in the lung (Ricciardolo 702
et al., 2004), but normal levels of exhaled NO match only the production quantity 703
from iNOS activation (Ialenti et al., 1993; Lane et al., 2004). 704
The NO turnover in the lungs is rapid, and part of the NO given off from 705
tissues to the gas phase is exhaled. A similar or even larger quantity is taken up by the 706
blood because NO binds very strongly to the haemoglobin in the blood. Thus, to fully 707
understand the NO turnover in the lungs, the rate of “back diffusion” of NO from its 708
site of formation in the airway wall to the lung alveoli must be assessed, as must the 709
rate of NO transfer from the alveolar space to the blood. 710
711
7.3. Effects of gravity and atmospheric pressure on exhaled NO 712
The atmospheric pressure in future habitats on the Moon and Mars, and in 713
vehicles made for interplanetary space missions, is likely to be substantially lower 714
than that on Earth due to the desire to minimise decompression times prior to 715
extravehicular activity. Studies have shown that normal healthy control values of 716
exhaled NO are reduced in microgravity (Karlsson et al., 2009). Moreover, 717
Hemmingson et al. ((2012)) have shown that pulmonary NO turnover is modified in 718
reduced ambient pressure even though the exhaled NO partial pressure is not changed 719
compared to normal ambient pressure. To establish normative values for exhaled NO 720
in future spaceflight environments, the combined effects of gravity and cabin pressure 721
on exhaled NO will need to be assessed. 722
723
8. Pulmonary effects 724
NASA’s effort to understand the pulmonary toxicity of lunar dust has been 725
spearheaded by LADTAG. LADTAG has undertaken ground-based animal 726
experiments based on the use of archived lunar soil (Apollo 14) that has been stored in 727
NASA’s curation facility (http://www.lpi.usra.edu/captem/). The primary motivation 728
for these experiments has been to derive a permissible exposure limit (PEL) for 729
airborne lunar dust that is in the respirable size range, focusing on particles that are <3 730
µm in diameter and for which exposure below the PEL is unlikely to cause health 731
effects. The PEL will be used to set requirements for air quality for spacecraft and 732
habitats that can be used in the design of future exploration missions to the Moon. 733
For these studies (James, 2011; Rask et al., 2012) three different preparations 734
of Apollo 14 lunar dust were used: lunar dust processed in a stainless steel jet mill to 735
reduce particle size to < 3 μm; lunar dust processed by grinding in an oscillating ball 736
mill, using a zirconium oxide grinding jar with zirconium oxide balls; and lunar dust 737
that was not ground by any means, but was processed in a cyclone separator, to select 738
for < 3 μm particles (James, 2011; Rask et al., 2012). Grinding of the Apollo 14 lunar 739
dust specimens was necessary to generate adequate amounts of respirable size lunar 740
dust needed for future rodent inhalation toxicity experiments planned by LADTAG 741
(James, 2011). The three preparations of respirable lunar dust had comparable particle 742
size, as determined by laser diffraction in an aqueous suspension (Rask et al., 2012). 743
744
8.1. Intratracheal instillation studies 745
In a series of experiments performed at the National Institute of Occupational 746
Safety and Health (NIOSH, Morgantown, WV), LADTAG scientists carried out an 747
intratracheal instillation study in rats, using the three Apollo 14 preparations described 748
above, at doses of 1 mg, 2.5 mg and 7.5 mg per rat together with quartz (Min-U-Sil 5) 749
and titanium dioxide as strong responder and low responder controls, respectively 750
(Santana et al., 2010). Using bronchioalveolar lavage fluid cell counts, lactate 751
dehydrogenase levels, albumin, and total protein as markers of inflammation, these 752
experiments demonstrated that the inflammatory response in rats to lunar dust is 753
intermediate between that of the titanium dioxide and quartz controls, at 7 days and at 754
30 days post exposure. For these bronchioalveolar lavage fluid endpoints, the three 755
different preparations of lunar dust were not distinguishable. Based on the findings of 756
these lavage fluid studies, a preliminary permissible exposure limit of 1.0 mg/m3 (6 757
months, intermittent exposure) was determined, using a benchmark dose analysis 758
method (James, 2011). 759
760
8.2. Differences in toxicity of dust due to method of lunar dust preparation – 761
macrophage reactivity studies 762
Freshly-fractured quartz is more toxic than aged quartz, and the leading 763
explanation for this observation is the concept that mechanical disruption of quartz 764
results in the homolytic and heterolytic rupture of the silicon-oxygen bonds 765
(“mechanochemical activation”) (Fubini and Hubbard, 2003). Increased surface 766
radical content of the freshly-fractured material is well-correlated with enhanced 767
toxicity. This finding is ascribed to the higher reactivity of dangling bonds and their 768
potential to generate free radicals in aqueous solutions (Fubini, 1998; Fubini and 769
Hubbard, 2003). Is a similar process important for lunar dust, which is exposed to 770
continuous micrometeorite bombardment (Brunetto, 2009) (Figure 9)? The use of 771
three different preparations of Apollo 14 lunar dust in the intratracheal instillation 772
experiments performed by LADTAG provided a means of addressing this question 773
(James, 2011). Indeed, the macrophage reactivity studies suggest that differences in 774
chemical reactivity are in fact correlated with differences in biological response for 775
lunar dust. 776
Analysis of the three Apollo 14 lunar dust preparations revealed that the 777
material prepared by grinding in a zirconium oxide ball mill exhibited 7-fold greater 778
ability to generate hydroxyl radicals on addition to aqueous buffer, compared to jet-779
mill processed material or un-ground (cyclone separation only) lunar dust, as judged 780
by the terephthalate assay (Rask et al., 2012). One possible explanation for the 781
observed increased ability to generate hydroxyl radicals in the ball-mill prepared 782
material is an enhanced generation of dangling bonds compared to the other 783
preparation methods. When a degranulation assay (luminol chemiluminescence) was 784
used to analyze macrophages harvested via bronchioalveolar lavage in the LADTAG 785
studies described above, increased macrophage reactivity was observed after exposure 786
to the chemically reactive ball mill-prepared lunar dust, but not after exposure to the 787
other two preparations where less or no mechanochemical activation is expected 788
(Rask et al., 2012). The macrophage reactivity assay used for these studies was the 789
same as the assay used in studies of quartz that showed increased biological responses 790
for freshly ground material versus aged (Porter et al., 2002). 791
These findings support the concept that lunar dust toxicity is dependent on 792
lunar dust chemical reactivity, and processes that cause mechanochemical activation 793
contribute to this reactivity. Other processes that may cause increased lunar dust 794
chemical reactivity, such as particle radiation exposure or UV light exposure, may be 795
associated with enhanced toxicity as well (Figure 9). Additional ground-based 796
experiments with lunar simulants, lunar dust, and its crystalline and amorphous phases 797
might shed more light on the above findings. In situ measurement of the chemical 798
reactivity of lunar dust, as it actually exists on the surface of the Moon, is likely the 799
only way of assessing the net effects of multiple processes that may affect the 800
chemical reactivity of lunar dust (Loftus et al., 2010). 801
802
9. Knowledge gaps and recommendations 803
Tables 1 and 2 list the key knowledge gaps that exist for the physical and 804
chemical properties of lunar dust (Table 1) and for its physiological and health effects 805
(Table 2). It must be kept in mind that the samples of lunar material that were brought 806
back from the Moon during the Apollo era were not optimized for studies of their dust 807
component. Moreover, their chemical reactivity is unlikely to mirror that of lunar 808
material in situ, since they have not been exposed to radiation and micrometeoroid 809
impacts (Figure 9) for the last 40-50 years – nor have they been kept under vacuum. 810
Previous work on the toxic effects of lunar material and simulants of lunar 811
material in animal and cellular models has been made with the particles in aqueous 812
media to avoid the large losses of precious material typical of conventional inhalation 813
techniques. New techniques are now being developed which permit more economical 814
inhalation studies in small animals. These techniques include individual and well-815
controlled administration by nasal or intratracheal routes, the latter being the most 816
exact and economical. Previous work on animal and cellular models has not addressed 817
the effects of dust that has been “activated” with UV or proton radiation. Such studies 818
should be given a high priority in the future. None of the curated lunar samples exist 819
in a pristine state that preserves the surface reactive chemical aspects thought to be 820
present on the lunar surface. Studies using this material therefore carry with them 821
considerable uncertainty in terms of fidelity. As a consequence, in situ data on lunar 822
dust properties are required for the ground-based studies to quantify the toxicity of 823
dust exposure during future manned lunar missions. 824
Based upon the knowledge gaps presented in Tables 1 and 2, we recommend a 825
set of in situ measurements on the Moon, and a set of measurements in ground-based, 826
analogue environments. The central goal of the in situ measurements is to gain 827
sufficient understanding of the environment on the Moon, and of the physico-828
chemical features and surface reactivity of lunar dust, so that the toxic effects of lunar 829
dust can be mimicked and studied in ground-based experiments using both re-830
activated material of lunar origin and lunar dust simulants. 831
10. Summary 832
Exposure of humans to lunar dust is likely to give rise to toxic reactions and 833
should therefore be avoided, or at least minimized by undertaking a risk assessment 834
and instigating appropriate measures to reduce exposure. Limits for permissible 835
exposure must be based on scientific evidence, which is currently highly incomplete 836
or absent. Dust toxicity is determined by the abundance, size distribution and 837
chemical reactivity of dust particles. Chemical reactivity depends on the composition 838
of dust in interaction with mechanical impacts from meteoroids and the exposure to 839
proton and UV radiation in an environment free of oxygen and humidity. Currently 840
used simulants of lunar dust and existing samples of actual lunar material are useful 841
only for initial pilot experiments with cellular, animal and human experimental 842
models of astronaut exposure to lunar dust. In situ determinations of factors such as 843
abundance, size distribution and chemical reactivity of lunar dust particles are 844
essential for a proper assessment of the risks for humans during future manned 845
exploration of the Moon. 846
847
Acknowledgements 848
The authors comprise the Topical Team on the Toxicity of Lunar Dust 849
(T3LD), and wish to thank the European Space Agency (ESA) for financial support. 850
We thank two anonymous reviewers for suggestions that improved the manuscript. 851
WvW acknowledges funding from the Netherlands Space Office’s Principal 852
Investigator Preparatory Programme. DJL acknowledges funding from NASA’s 853
Human Research Program, as well as Center Investment Funds from NASA Ames 854
Research Center. GKP acknowledges funding from the National Space Biomedical 855
Research Institute (NSBRI) through NASA NCC 9-58. 856
References 857
858 859 Alving, K., Weitzberg, E., Lundberg, J.M., 1993. Increased amount of nitric oxide in 860
exhaled air of asthmatics. Eur. Resp. J. 6, 1368-1370. 861 Asano, K., Chee, C.B., Gaston, B., Lilly, C.M., Gerard, C., Drazen, J.M., Stamler, 862
J.S., 1994. Constitutive and inducible nitric oxide synthase gene expression, 863 regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. 864 U.S.A. 91, 10089-10093. 865
Basu, A., Wentworth, S.J., McKay, D.S., 2001. Submillimeter grain-size distribution 866 of Apollo 11 soil 10084. Meteor. Planet. Sci. 36, 171-181. 867
Bosquillon, C., Preat, V., Vanbever, R., 2004. Pulmonary delivery of growth hormone 868 using dry powders and visualization of its local fate in rats. J. Control. Rel. 96, 869 233-244. 870
Brain, J.D., Godleski, J., Kreyling, W., 1994. In vivo evaluation of chemical 871 biopersistence of nonfibrous inorganic particles. Environ Health Perspect. 102 872 Suppl 5, 119-125. 873
Brown, D.M., Beswick, P.H., Bell, K.S., Donaldson, K., 2000. Depletion of 874 glutathione and ascorbate in lung lining fluid by respirable fibres. Ann. Occup. 875 Hyg. 44, 101-108. 876
Brunetto, R., 2009. Space Weathering of Small Solar System Bodies. Earth Moon 877 Planets 105, 249-255. 878
Butler, J.P., Tsuda, A., 1998. Effect of convective stretching and folding on aerosol 879 mixing deep in the lung, assessed by approximate entropy. J. Appl. Physiol. 83, 880 800-809. 881
Cain, J.R., 2010. Lunar dust: The hazard and astronaut exposure risks. Earth Moon 882 Planets 107, 107-125. 883
Cain, J.R., 2011. Astronautical hygiene - A new discipline to protect the health of 884 astronauts working in space. J. Brit. Interplanet. Soc. 64, 179-185. 885
Castranova, V., Vallyathan, V., Ramsey, D.M., McLaurin, J.L., Pack, D., Leonard, S., 886 Barger, M.W., Ma, J.Y.C., Dalal, N.S., Teass, A., 1997. Augmentation of 887 pulmonary reactions to quartz inhalation by trace amounts of iron-containing 888 particles. Environ. Health Perspect. 105, 1319-1324. 889
Christoffersen, R., Lindsay, J.F., Noble, S.K., Meador, M.A., Kosmo, J.J., Lawrence, 892 J.A., Brostoff, L., Young, A., McCue, T., 2009. Lunar dust effects on spacesuit 893 systems: Insights from the Apollo spacesuits. NASA/TP 2009-214786. 894
Crawford, I.A., Anand, M., Cockell, C.S., Falcke, H., Green, D.A., Jaumann, R., 895 Wieczorek, M., 2012. Back to the Moon: the scientific rationale for resuming lunar 896 surface exploration. Planet. Space Sci. this volume. 897
Damm, C., Peukert, W., 2009. Kinetics of radical formation during the mechanical 898 activation of quartz. Langmuir 25, 2264-2270. 899
Darquenne, C., Paiva, M., West, J.B., Prisk, G.K., 1997. Effect of microgravity and 900 hypergravity on deposition of 0.5- to 3-µm-diameter aerosol in the human lung. J. 901 Appl. Physiol. 83, 2029-2036. 902
Darquenne, C., Prisk, G., 2008. Deposition of inhaled particles in the human lung is 903 more peripheral in lunar than in normal gravity. Eur. J. Appl. Physiol. 103, 687-904 695. 905
Darquenne, C., Prisk, G.K., 2004. Effect of small flow reversals on aerosol mixing in 906 the alveolar region of the human lung. J. Appl. Physiol. 97, 2083-2089. 907
Darquenne, C., West, J.B., Prisk, G.K., 1998. Deposition and dispersion of 1 µm 908 aerosol boluses in the human lung: Effect of micro- and hypergravity. J. Appl. 909 Physiol. 85, 1252-1259. 910
Darquenne, C., West, J.B., Prisk, G.K., 1999. Dispersion of 0.5-2 µm aerosol in 911 micro- and hypergravity as a probe of convective inhomogeneity in the human 912 lung. J. Appl. Physiol. 86, 1402-1409. 913
Dockery, D.W., Pope, C.A., 3rd, Xu, X., Spengler, J.D., Ware, J.H., Fay, M.E., Ferris, 914 B.G., Jr., Speizer, F.E., 1993. An association between air pollution and mortality in 915 six U.S. cities. New Engl. J. Med. 329, 1753-1759. 916
Driscoll, K.E., Costa, D.L., Hatch, G., Henderson, R., Oberdorster, G., Salem, H., 917 Schlesinger, R.B., 2000. Intratracheal instillation as an exposure technique for the 918 evaluation of respiratory tract toxicity: uses and limitations. Toxicol. Sci. 55, 24-919 35. 920
Ewing, P., Blomgren, B., Ryrfeldt, A., Gerde, P., 2006. Increasing exposure levels 921 cause an abrupt change in the absorption and metabolism of acutely inhaled 922 benzo(a)pyrene in the isolated, ventilated, and perfused lung of the rat. Toxicol. 923 Sci. 91, 332-340. 924
Fanizza, C., Ursini, C.L., Paba, E., Ciervo, A., DiFrancesco, A., Maiello, R., 925 DeSimone, P., Cavallo, D., 2007. Cytotoxicity and DNA-damage in human lung 926 epithelial cells exposed to respirable alpha-quartz. Toxicol. In Vitro 21, 586-594. 927
Fenoglio, I., Coluccia, S., Martra, G., Prandi, L., Tomatis, M., Fubini, B., 2001. The 928 role of mechanochemistry in the pulmonary toxicity caused by particulate 929 minerals. J. Mat. Synth. Proc. 8, 145-154. 930
Fenoglio, I., Fonsato, B., Fubini, B., 2003. Reaction of cysteine and glutathione 931 (GSH) at the freshly fractured quartz surface: a possible role in silica related 932 diseases? . Free Rad. Biol. Med. 35, 752-762. 933
Fenoglio, I., Greco, G., Livraghi, S., Fubini, B., 2009. Non-UV-induced radical 934 reactions at the surface of TiO2 nanoparticles that may trigger toxic responses 15, 935 4514-4621. 936
Fenoglio, I., Martra, G., Coluccia, S., Fubini, B., 2000. On the possible role of 937 ascorbic acid in the oxidative damage induced by inhaled silica particles. Chem. 938 Res. Toxicol. 13, 971-975. 939
Frampton, M.W., Stewart, J.C., Oberdorster, G., Morrow, P.E., Chalupa, D., 940 Pietropaoli, A.P., Frasier, L.M., Speers, D.M., Cox, C., Huang, L.S., Utell, M.J., 941 2006. Inhalation of ultrafine particles alters blood leukocyte expression of adhesion 942 molecules in humans. Environ. Health Perspect. 114, 51-58. 943
Fubini, B., 1998. Health effects of silica, In: Legrand, J.P. (Ed.), The surface 944 properties of silicas. J. Wiley and Sons, Chichester, pp. 415-464. 945
Fubini, B., Fenoglio, I., 2007. Toxic potential of mineral dusts. Elements 3, 407-414. 946 Fubini, B., Fenoglio, I., Elias, Z., Poirot, O., 2001. Variability of biological responses 947
to silicas: effect of origin, crystallinity, and state of surface on generation of 948 reactive oxygen species and morphological transformation of mammalian cells. J. 949 Env. Pathol. Toxicol. Onc. 20, 95-108. 950
Fubini, B., Fenoglio, I., Tomatis, M., Turci, F., 2011. Effect of chemical composition 951 and state of the surface on the toxic response to high aspect ratio nanomaterials 952 (HARNS) Nanomedicine 6, 899-920. 953
Fubini, B., Ghiazza, M., Fenoglio, I., 2010. Physico-chemical features of engineered 954 nanoparticles relevant to their toxicity. Nanotoxicology 4, 347-363. 955
Fubini, B., Hubbard, A., 2003. Reactive Oxygen Species (ROS) and Reactive 956 Nitrogen Species (RNS) generation by silica in inflammation and fibrosis. Free 957 Rad. Biol. Med. 34, 1507-1516. 958
Fubini, B., Otero-Arean, C., 1999. Chemical aspects of the toxicity of inhaled mineral 959 dusts. Chem. Soc. Rev. 28, 373-381. 960
Fubini, B., Zanetti, G., Altilia, S., Tiozzo, R., Lison, D., Saffiotti, U., 1999. 961 Relationship between surface properties and cellular responses to crystalline silica: 962 studies with heat-treated cristobalite. Chem. Res. Toxicol. 12, 737-745. 963
Fujishima, A., Zhang, X., Tryk, D.A., 2008. TiO2 photocatalysis and related surface 964 phenomena. Surf. Sci. Rep. 63, 515-582. 965
Gaier, J.R., Meador, M.A., Rogers, K.J., Sheehy, B.H., 2009. Abrasion of Candidate 966 Spacesuit Fabrics by Simulated Lunar Dust. NASA Glenn Research Center. 967
Gazzano, E., Ghiazza, M., Polimeni, M., Bolis, V., Fenoglio, I., Fubini, B., Ghigo, D., 968 submitted. Physico-chemical determinants in the cellular responses to amorphous 969 silica nanoparticles. Toxicol. Sci. 970
Geiser, M., Kreyling, W.G., 2010. Deposition and biokinetics of inhaled 971 nanoparticles. Part. Fibre Toxicol. 7, 2. 972
Gerde, P., Ewing, P., Låstbom, L., Waher, J., Lidén, G., Ryrfeldt, Å., 2004. A novel 973 method to aerosolize powder for short inhalation exposures at high concentrations: 974 Isolated rat lungs exposed to respirable diesel soot. Inhal. Toxicol. 16, 45-52. 975
Gerde, P., Muggenburg, B.A., Lundblad, M., Dahl, A.R., 2001. The rapid alveolar 976 absorption of diesel-soot adsorbed benzo(a)pyrene-Bioavailability, metabolism, 977 and dosimetry of an inhaled carcinogen. Carcinogenesis 22, 741-749. 978
Ghiazza, M., Polimeni, M., Fenoglio, I., Gazzano, E., Ghigo, D., Fubini, B., 2010. 979 Does vitreous silica contradict the toxicity of crystalline silica paradigm? Chem. 980 Res. Toxicol. 23. 981
Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and 984 humans. Biochem. Ciophys. Res. Comm. 181, 852-857. 985
Hardy, J.A., Aust, A.E., 1995a. The effect of iron-binding on the ability of crocidolite 986 asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16, 319-325. 987
Hardy, J.A., Aust, A.E., 1995b. Iron in asbestos chemistry and carcinogenicity. Chem. 988 Rev. 95, 97-118. 989
Harmsen, A.G., Muggenburg, B.A., Snipes, M.B., Bice, D.E., 1985. The role of 990 macrophages in particle translocation from lungs to lymph nodes. Science 230, 991 1277-1280. 992
Heinrich, U., Fuhst, R., Rittinghausen, S., Creutzenberg, O., Bellmann, B., Koch, W., 993 Levsen, K., 1995. Chronic inhalation exposure of wistar rats and two different 994 strains of mice to diesel engine exhaust, carbon black, and titanium dioxide. Inhal. 995 Toxicol. 7, 533-556. 996
Hemmingsson, T.E., Linnarsson, D., Frostell, C., Van Muylem, A., Kerckx, Y., 997 Gustafsson, L.E., (2012). Effects of ambient pressure on pulmonary nitric oxide. J. 998 Appl. Physiol. 112, 580-586. 999
Heyder, J., Blanchard, J.D., Feldman, H.A., Brain, J.D., 1988. Convective mixing in 1000 human respiratory tract: estimates with aerosol boli. J. Appl. Physiol. 64, 1273-1001 1278. 1002
Hill, E., Melling, M.J., Deane, B., Liu, Y., Taylor, L.A., 2007. Apollo sample 70051 1003 and high- and low-Ti lunar soil simulants MLS-1A and JSC-1A: implications for 1004 future lunar exploration. J. Geophys. Res. 112, E02006. 1005
Hong, Y.C., Lee, J.T., Kim, H., Kwon, H.J., 2002. Air pollution: a new risk factor in 1006 ischemic stroke mortality. Stroke 33, 2165-2169. 1007
Horanyi, M., Stern, A., 2011. Lunar dust, atmosphere and plasma: The next steps. 1008 Planet. Space Sci. 59, 1671. 1009
Horwell, C.J., Fenoglio, I., Fubini, B., 2007. Iron-induced hydroxyl radical generation 1010 from basaltic volcanic ash. Earth Planet. Sci. Lett. 261, 662-669. 1011
Horwell, C.J., Stannett, G.W., Andronico, D., Bertagnini, A., Fenoglio, I., Fubini, B., 1012 Le Blond, J.S., Williamson, B.J., 2010. A physico-chemical assessment of the 1013 health hazard of Mt. Vesuvius volcanic ash. J. Volcanol. Geotherm. Res. 191, 222-1014 232. 1015
Hurowitz, J.A., Tosca, N.J., McLennan, S.M., Schoonen, M.A.A., 2007. Production 1016 of hydrogen peroxide in Martian and lunar soils. Earth Planet. Sci. Lett. 255, 41-1017 52. 1018
Ialenti, A., Moncada, S., Di Rosa, M., 1993. Modulation of adjuvant arthritis by 1019 endogenous nitric oxide. Brit. J. Pharmacol. 110, 701-706. 1020
IARC, 1997. Silica, some silicates, coal dusts, and para-amid fibrils. IARC Monogr. 1021 68. 1022
IARC, 2010. Carbon black, titanium dioxide, and talc. IARC Monogr. 93. 1023 IARC, 2011. A review of human carcinogens: Arsenic, Metals, Fibres and Dusts. 1024
Endothelium-derived relaxing factor produced and released from artery and vein is 1027 nitric oxide. Proc. Natl. Acad. Sci. U S A 84, 9265-9269. 1028
James, J.T., 2011. LADTAG progress 2010 and plans for 2011 and provisional PELs 1029 from lavage and blood data. 1030
James, J.T., Khan-Mayberry, N., 2009. Risk of adverse health effects from lunar dust 1031 exposure, In: McPhee, J.C., Charles, J.B. (Eds.), Human Health and Performance 1032 Risks for Space Exploration Missions. National Aeronautics and Space 1033 Administration, pp. 317-333. 1034
Jones, J., Hoffman, R., Harvey, C., Bowen, C.K., Hudy, C.E., Tuxhorn, J., Gernhardt, 1035 M., Scheuring, R.A., 2007. Mechanisms of injury and countermeasures for EVA 1036 associated upper extremity medical issues: Extended vent tube study. NASA 1037 Johnson Space Center. 1038
Kamp, D.W., Weitzman, S.A., 1999. The molecular basis of asbestos induced lung 1039 injury. Thorax 54, 638-652. 1040
Kane, A.B., 1996. Mechanisms of mineral fibre carcinogenesis, In: Kane, A.B., 1041 Boffetta, P., Saracci, R., Wilburn, J.D. (Eds.), Mechanisms of fibre carcinogenesis. 1042 International Agency for Research on Cancer Scientific Publication, pp. 11-35. 1043
Karlsson, L.L., Kerckx, Y., Gustafsson, L.E., Hemmingsson, T.E., Linnarsson, D., 1044 2009. Microgravity decreases and hypergravity increases exhaled nitric oxide. J. 1045 Appl. Physiol. 107, 1431-1437. 1046
Khan-Mayberry, N., 2007. The Lunar environment: Determining the health effects of 1047 exposure to Moon dusts. NASA Johnson Space Center. 1048
Kharitonov, S.A., 2004. Exhaled markers of inflammatory lung diseases: ready for 1049 routine monitoring? Swiss Med. Wkly. 134, 175-192. 1050
Kharitonov, S.A., Barnes, P.J., 2001. Exhaled markers of pulmonary disease. Am. J. 1051 Respir. Crit. Care Med. 163, 1693-1722. 1052
Kobrick, R.L., Klaus, D.M., Street, K.W., Jr., 2010. Defining an abrasion index for 1053 lunar surface systems as a Function of dust interaction modes and variable 1054 concentration zones. 1055
Lam, C.W., James, J.T., McCluskey, R., Cowper, S., Balis, J., Muro-Cacho, C., 2002. 1056 Pulmonary toxicity of simulated lunar and Martian dusts in mice: I. Histopathology 1057 7 and 90 days after intratracheal instillation. Inhal. Toxicol. 14, 901-916. 1058
Lane, C., Knight, D., Burgess, S., Franklin, P., Horak, F., Legg, J., Moeller, A., Stick, 1059 S., 2004. Epithelial inducible nitric oxide synthase activity is the major determinant 1060 of nitric oxide concentration in exhaled breath. Thorax 59, 757-760. 1061
Latch, J.N., Hamilton, R.F., Jr., Holian, A., James, J.T., Lam, C.W., 2008. Toxicity of 1064 lunar and martian dust simulants to alveolar macrophages isolated from human 1065 volunteers. Inhal. Toxicol. 20, 157-165. 1066
Lison, D., Carbonnelle, P., Mollo, L., Lauwerys, R., Fubini, B., 1995. 1067 Physicochemical mechanism of the interaction between cobalt metal and carbide 1068 particles to generate toxic activated oxygen species Chem. Res. Toxicol. 8, 600-1069 606. 1070
Lison, D., Laloy, J., Corazzari, I., Muller, J., Rabolli, V., Panin, N., Huaux, F., 1071 Fenoglio, I., Fubini, B., 2009. Sintered indium-tin-oxide (ITO) particles:a new 1072 pneumotoxic entity Toxicol. Sci. 108, 472-481. 1073
Liu, Y., Park, J., Schnare, D., Hill, E., Taylor, L.A., 2008. Characterization of luanr 1074 dust for toxicological studies. II: Morphology and physical characteristics. J. 1075 Aerosp. Eng. 21. 1076
Liu, Y., Taylor, L.A., 2011. Characterization of lunar dust and a synopsis of available 1077 lunar simulants. Planet. Space Sci. 59, 1769-1783. 1078
Loftus, D.J., Rask, J.C., McCrossin, C.G., Tranfield, E.M., 2010. The chemical 1079 reactivity of lunar dust: from toxicity to astrobiology. Earth Moon Planet. 107, 95-1080 105. 1081
Lucey, P., Korotev, R.L., Gillis, J.J., Taylor, L.A., Lawrence, D., Campbell, B.A., 1082 Elphic, R., Feldman, B., Hood, L.L., Hunten, D., Mendillo, M., Noble, S., Papike, 1083 J.J., Reedy, R.C., Lawson, S., Prettyman, T., Gasnault, O., Maurice, S., 2006. 1084 Understanding the lunar surface and space-Moon interactions. Rev. Mineral. 1085 Geochem. 60, 83-219. 1086
Lundberg, J.O., Farkas-Szallasi, T., Weitzberg, E., Rinder, J., Lidholm, J., Anggaard, 1087 A., Hokfelt, T., Lundberg, J.M., Alving, K., 1995. High nitric oxide production in 1088 human paranasal sinuses. Nature Med. 1, 370-373. 1089
delivery to a mechanically ventilated rodent. J. Aerosol Med. Pulm. Drug Del. 22, 1092 323-332. 1093
McClellan, R.O., Henderson, R.F., 1995. Concepts in inhalation toxicology, 2 ed. 1094 Taylor and Francis, Washington DC, p. 648. 1095
McKay, D.S., Carter, J.L., Boles, W.W., Allen, C.C., Allton, J.H., 1994. JSC-1: a new 1096 lunar soil simulant. Space IV, 857-866. 1097
McKay, D.S., Heiken, G., Basu, A., Blanford, G., Simon, S., Reedy, R., French, B.M., 1098 Papike, J., 1991. The lunar regolith, In: Heiken, G., Vaniman, D., French, B. 1099 (Eds.), Lunar Sourcebook. Cambridge University Press, New York, pp. 286-356. 1100
Moller, W., Haussinger, K., Winkler-Heil, R., Stahlhofen, W., Meyer, T., Hofmann, 1101 W., Heyder, J., 2004. Mucociliary and long-term particle clearance in the airways 1102 of healthy nonsmoker subjects. J. Appl. Physiol. 97, 2200-2206. 1103
Mossman, B.T., Bignon, J., Corn, M., Seaton, A., Gee, J.B., 1990. Asbestos: scientific 1104 developments and implications for public policy. Science 247, 294-301. 1105
NASA Manned Spacecraft Center, 1973. Apollo 17 technical crew debriefing, 1106 Houston, Texas. 1107
Nel, A., Maedler, L., Velegol, D., Xia, T., Hoek, E.M.V., Somasundaran, P., Klaessig, 1108 F., Castranova, V., Thompson, M., 2009. Understanding biophysicochemical 1109 interactions at the nano–bio interface Nature Mat. 8, 543-557. 1110
Nel, A., Xia, T., Maedler, L., Li, N., 2006. Toxic potential of materials at the 1111 nanolevel. Science 311, 622-627. 1112
Nemmar, A., Hoet, P.H., Vanquickenborne, B., Dinsdale, D., Thomeer, M., Hoylaerts, 1113 M.F., Vanbilloen, H., Mortelmans, L., Nemery, B., 2002. Passage of inhaled 1114 particles into the blood circulation in humans. Circulation 105, 411-414. 1115
Nikula, K.J., Snipes, M.B., Barr, E.B., Griffith, W.C., Henderson, R.F., Mauderly, 1116 J.L., 1995. Comparative pulmonary toxicities and carcinogenicities of chronically 1117 inhaled diesel exhaust and carbon black in F344 rats. Fund. Appl. Toxicol. 25, 80-1118 94. 1119
Norde, W., 2008. My voyage of discovery to proteins in flatland ...and beyond. 1120 Colloids Surf. B: Biointerfaces 61, 1-9. 1121
Oberdörster, G., Finkelstein, J.N., Johnston, C., Gelein, R., Cox, C., Baggs, R., Elder, 1122 A.C., 2000. Acute pulmonary effects of ultrafine particles in rats and mice. Res. 1123 Rep. (Health Effects Inst.) 96, 5-74. 1124
Oberdörster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., 1125 Ausman, K., Carter, J., Karn, B., Kreyling, W., Lai, D., Olin, S., Monteiro-Riviere, 1126 N., Warheit, D., Yang, H., 2005a. Principles for characterizing the potential human 1127 health effects from exposure to nanomaterials: elements of a screening strategy. 1128 Part. Fibre Toxicol. 2, 8. 1129
Oberdörster, G., Oberdörster, E., Oberdörster, J., 2005b. Nanotoxicology: an 1130 emerging discipline evolving from studies of ultrafine particles. Environ. Health 1131 Perspect. 113, 823-839. 1132
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., Cox, C., 1133 2004. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16, 1134 437-445. 1135
Park, J., Liu, Y., Kihm, K.D., Taylor, L.A., 2008. Characterization of lunar dust for 1136 toxicological studies. I: Particle Size Distribution. J. Aerosp. Eng. 21, 266-271. 1137
Parsegian, V.A., 2006. Van der Waals forces - A handbook for biologists, chemists, 1138 engineers, and physicists. Cambridge University Press, Cambridge. 1139
Patil, S.U., Long, A.A., 2010. The usefulness of biomarkers of airway inflammation 1140 in managing asthma. Allergy Asthma Proc. 31, 259-268. 1141
Pauluhn, J., 1994. Validation of an improved nose-only exposure system for rodents. 1142 J. Appl. Toxicol. 14, 55-62. 1143
Pawloski, J.R., Hess, D.T., Stamler, J.S., 2001. Export by red blood cells of nitric 1146 oxide bioactivity. Nature 409, 622-626. 1147
Persson, M.G., Zetterstrom, O., Agrenius, V., Ihre, E., Gustafsson, L.E., 1994. Single-1148 breath nitric oxide measurements in asthmatic patients and smokers. Lancet 343, 1149 146-147. 1150
Peters, A., Liu, E., Verrier, R.L., Schwartz, J., Gold, D.R., Mittleman, M., Baliff, J., 1151 Oh, J.A., Allen, G., Monahan, K., Dockery, D.W., 2000. Air pollution and 1152 incidence of cardiac arrhythmia. Epidemiology 11, 11-17. 1153
Peters, A., Veronesi, B., Calderon-Garciduenas, L., Gehr, P., Chen, L.C., Geiser, M., 1154 Reed, W., Rothen-Rutishauser, B., Schurch, S., Schulz, H., 2006. Translocation 1155
and potential neurological effects of fine and ultrafine particles a critical update. 1156 Part. Fibre Toxicol. 3, 13. 1157
Peters, A., von Klot, S., Heier, M., Trentinaglia, I., Hormann, A., Wichmann, H.E., 1158 Lowel, H., 2004. Exposure to traffic and the onset of myocardial infarction. New 1159 Engl. J. Med. 351, 1721-1730. 1160
Peterson, J.B., Prisk, G.K., Darquenne, C., 2008. Aerosol deposition in the human 1161 lung periphery is increased by reduced-density gas breathing. J. Aerosol Med. 1162 Pulm. Drug Del. 21, 159-168. 1163
Pezerat, H., Zalma, R., Guignard, J., Jaurand, M.C., 2007. Production of oxygen 1164 radicals by the reduction of oxygen arising from the surface activity of mineral 1165 fibres. IARC Scientific Pub. 90, 100-111. 1166
Pope, C.A., 3rd, Burnett, R.T., Thurston, G.D., Thun, M.J., Calle, E.E., Krewski, D., 1167 Godleski, J.J., 2004. Cardiovascular mortality and long-term exposure to 1168 particulate air pollution: epidemiological evidence of general pathophysiological 1169 pathways of disease. Circulation 109, 71-77. 1170
Pope, C.A., 3rd, Verrier, R.L., Lovett, E.G., Larson, A.C., Raizenne, M.E., Kanner, 1171 R.E., Schwartz, J., Villegas, G.M., Gold, D.R., Dockery, D.W., 1999. Heart rate 1172 variability associated with particulate air pollution. Am Heart J. 138, 890-899. 1173
Popov, T.A., 2011. Human exhaled breath analysis. Ann. Allergy Asthma Immunol. 1174 106, 451-456. 1175
Porter, D.W., Barger, M., Robinson, V.A., Leonard, S.S., Landsittel, D., Castranova, 1176 V., 2002. Comparison of low doses of aged and freshly fractured silica on 1177 pulmonary inflammation and damage in the rat. Toxicol. 175, 63-71. 1178
Ricciardolo, F.L., Sterk, P.J., Gaston, B., Folkerts, G., 2004. Nitric oxide in health and 1183 disease of the respiratory system. Physiol. Rev. 84, 731-765. 1184
Saffiotti, U., Cefis, F., Kolb, L.H., 1968. A method for the experimental induction of 1185 bronchogenic carcinoma. Cancer Res. 28, 104-124. 1186
Sahai, N., 2002. Is silica really an anomalous oxide? Surface acidity and aqueous 1187 hydrolysis revisited. Environ. Sci. Tech. 36, 445-452. 1188
Sakagami, M., 2006. In vivo, in vitro and ex vivo models to assess pulmonary 1189 absorption and disposition of inhaled therapeutics for systemic delivery. Adv. Drug 1190 Deliv. Rev. 58, 1030-1060. 1191
Sakagami, M., Kinoshita, W., Sakon, K., Makino, Y., 2003. Fractional contribution of 1192 lung, nasal and gastrointestinal absorption to the systemic level following nose-1193 only aerosol exposure in rats: a case study of 3.7- micro m fluorescein aerosols. 1194 Arch. Toxicol. 77, 321-329. 1195
Samet, J.M., Dominici, F., Curriero, F.C., Coursac, I., Zeger, S.L., 2000. Fine 1196 particulate air pollution and mortality in 20 U.S. cities, 1987-1994. New Engl. J. 1197 Med. 343, 1742-1749. 1198
Sanchez, V.C., Pietruska, J.R., Miselis, N.R., Hurt, R.H., Kane, A.B., 2009. 1199 Biopersistence and potential adverse health impacts of fibrous nanomaterials: what 1200 have we learned from asbestos? Nanomed. Nanobiotechn. 1, 511-529. 1201
Scheuch, G., Stahlhofen, W., Heyder, J., 1996. An approach to deposition and 1204 clearance measurements in human airways. J. Aerosol Med. 9, 35-41. 1205
Schwartz, J., 1994. What are people dying of on high air pollution days? Environ. 1206 Res. 64, 26-35. 1207
Seagrave, J., McDonald, J.D., Bedrick, E., Edgerton, E.S., Gigliotti, A.P., Jansen, J.J., 1208 Ke, L., Naeher, L.P., Seilkop, S.K., Zheng, M., Mauderly, J.L., 2006. Lung toxicity 1209 of ambient particulate matter from southeastern U.S. sites with different 1210 contributing sources: relationships between composition and effects. Environ. 1211 Health Persp. 114, 1387-1393. 1212
Seaton, A., MacNee, W., Donaldson, K., Godden, D., 1995. Particulate air pollution 1213 and acute health effects. Lancet 345, 176-178. 1214
Seaton, A., Soutar, A., Crawford, V., Elton, R., McNerlan, S., Cherrie, J., Watt, M., 1215 Agius, R., Stout, R., 1999. Particulate air pollution and the blood. Thorax 54, 1027-1216 1032. 1217
Selg, E., Acevedo, F., Nybom, R., Blomgren, B., Ryrfeldt, Å., Gerde, P., 2010. 1218 Delivering Horseradish Peroxidase as a Respirable Powder to the Isolated, 1219 Perfused and Ventilated Lung of the Rat: The Pulmonary Disposition of an Inhaled 1220 Model Biopharmaceutical. J. Aerosol Med. Pulm. Drug Del. 23, 273-284. 1221
Semmler, M., Seitz, J., Erbe, F., Mayer, P., Heyder, J., Oberdorster, G., Kreyling, 1222 W.G., 2004. Long-term clearance kinetics of inhaled ultrafine insoluble iridium 1223 particles from the rat lung, including transient translocation into secondary organs. 1224 Inhal. Toxicol. 16, 453-459. 1225
Shukla, A., Gulumian, M., Hei, T.K., Kamp, D.W., Rahman, Q., Mossman, B.T., 1226 2003. Multiple roles of oxidants in te pathogenesis of asbestos-induced diseases. 1227 Free Radical Biol. Med. 34, 1117-1129. 1228
Smaldone, G.C., Perry, R.J., Bennett, W.D., Messina, M.S., Zwang, J., Ilowite, J.S., 1229 1988. Interpretation of "24 hour lung retention" in studies of mucociliary clearance. 1230 J. Aerosol Med. 1, 11-20. 1231
Stahlhofen, W., et al., 1989. Intercomparison of experimental regional aerosol 1232 deposition data. J. Aerosol. Med. 2, 285-308. 1233
Stanton, M.F., Layard, M., Tegeris, A., Miller, E., May, M., Morgan, E., Smith, A., 1234 1981. Relation of particle dimension to carcinogenicity in amphibole asbestoses 1235 and other fibrous minerals. J. Nat. Cancer Inst. 67, 965-975. 1236
Sundblad, B.M., Larsson, B.M., Palmberg, L., Larsson, K., 2002. Exhaled nitric oxide 1237 and bronchial responsiveness in healthy subjects exposed to organic dust. Eur. 1238 Resp. J. 20, 426-431. 1239
Taylor, L.A., Pieters, C.M., Keller, L.P., Morris, R.V., McKay, D.S., 2001a. Lunar 1242 mare soils: Space weathering and the major effects of surface-correlated nanophase 1243 Fe. J. Geophys. Res. 106, 27985-27999. 1244
Taylor, L.A., Pieters, C.M., Keller, L.P., Morris, R.V., McKay, D.S., Patchen, A., 1245 Wentworth, S.J., 2001b. The effects of space weathering on Apollo 17 mare soils: 1246 petrographic and chemical characterization. Meteor. Planet. Sci. 36, 288-299. 1247
Taylor, L.A., Pieters, C.M., Patchen, A., Taylor, D.-H.S., Morris, R.V., Keller, L.P., 1248 McKay, D.S., 2010. Mineralogical and chemical characterization of lunar highland 1249 soils: Insights into the space weathering of soils on airless bodies. J. Geophys. Res. 1250 115, doi:10.1029/2009JE003427. 1251
Taylor, L.A., Schmitt, H.H., Carrier, W.D., Nakagawa, M., 2005. The lunar dust 1252 problem: from liability to asset, Proceedings of the First Space Exploration 1253 Conference, p. 2150. 1254
Thompson, M., Christoffersen, R., 2010. The smallest lunar grains: analytical TEM 1255 characterization of the sub-micron size fraction of a mare soil. Lunar Planet. Sci. 1256 Conf. 41, 2191. 1257
Tranfield, E.M., van Eeden, S.F., Yatera, K., Hogg, J.C., Walker, D.C., 2010. 1258 Ultrastructural changes in atherosclerotic plaques following the instillation of 1259 airborne particulate matter into the lungs of rabbits. Can. J. Cardiol. 26, 258-269. 1260
Tronde, A., Baran, G., Eirefelt, S., Lennernas, H., Bengtsson, U.H., 2002. 1261 Miniaturized nebulization catheters: a new approach for delivery of defined aerosol 1262 doses to the rat lung. J. Aerosol Med. 15, 283-296. 1263
Tsuda, A., Rogers, R.A., Hydon, P.E., Butler, J.P., 2002. Chaotic mixing deep in the 1264 lung. Proc. Natl. Acad. Sci. U.S.A. 99, 10173-10178. 1265
Turci, F., Ghibaudi, E., Colonna, M., Boscolo, B., Fenoglio, I., Fubini, B., 2010. An 1266 integrated approach for the study of the interaction between proteins and 1267 nanoparticles. Langmuir 26, 8336-8346. 1268
Turci, F., Tomatis, M., Lesci, I.G., Roveri, N., Fubini, B., 2011. The iron-related 1269 molecular toxicity mechanism of synthetic asbestos nanofibres: a model study for 1270 high-aspect-ratio nanoparticles. Chem. Eur. J. 7, 350-358. 1271
Vallyathan, V., Shi, X., Dalal, N.S., Irr, W., Castranova, V., 1988. Generation of free 1272 radicals from freshly fractured silica dust. Potential role in acute silica-induced 1273 lung injury. Am. Rev. Resp. Dis. 138, 1213-1219. 1274
van Eeden, S.F., Tan, W.C., Suwa, T., Mukae, H., Terashima, T., Fujii, T., Qui, D., 1275 Vincent, R., Hogg, J.C., 2001. Cytokines involved in the systemic inflammatory 1276 response induced by exposure to particulate matter air pollutants (PM(10)). Am. J. 1277 Respir. Crit. Care Med. 164, 826-830. 1278
von Klot, S., Peters, A., Aalto, P., Bellander, T., Berglind, N., D'Ippoliti, D., Elosua, 1279 R., Hormann, A., Kulmala, M., Lanki, T., Lowel, H., Pekkanen, J., Picciotto, S., 1280 Sunyer, J., Forastiere, F., 2005. Ambient air pollution is associated with increased 1281 risk of hospital cardiac readmissions of myocardial infarction survivors in five 1282 European cities. Circulation 112, 3073-3079. 1283
Wallace, W.T., Phillips, C.J., Jeevarajan, A.Y.S., Chen, B., Taylor, L.A., 2010. 1284 Nanophase iron-enhanced chemical reactivity of ground lunar soil. Earth Planet. 1285 Sci. Lett. 295, 571-577. 1286
Warheit, D.B., Sayes, C.M., Reed, K.L., Swain, K.A., 2008. Health effects related to 1287 nanoparticle exposures: environmental, health and safety considerations for 1288 assessing hazards and risks. Pharmacol. Therap. 120, 35-42. 1289
Warheit, D.B., Webb, T.R., Reed, K.L., 2007. Pulmonary toxicity screening studies in 1290 male rats with M5 respirable fibers and particulates. Inhal. Toxicol. 19, 951-963. 1291
West, J.B., 2001. Pulmonary Physiology and Pathophysiology. Lippincott Williams & 1292 Wilkins, Baltimore. 1293
Zanobetti, A., Schwartz, J., 2001. Are diabetics more susceptible to the health effects 1296 of airborne particles? Am. J. Resp. Crit. Care Med. 164, 831-833. 1297
Figure captions 1298
Figure 1. (a) Apollo 17 astronaut Gene Cernan covered in dust after extravehicular 1299
activity on the lunar surface (photograph courtesy NASA). (b) Size distribution of n = 1300
840 grains recovered from the spacesuit of Apollo 17 astronaut Harrison Schmitt, with 1301
a mean of 10.7 μm. Modified from Christoffersen et al. (2009). 1302
1303
Figure 2. Steps of cell and tissue interaction with nano and micron-sized particles in 1304
the lung. When attained the alveolar space the particle may react with endogenous 1305
molecules (step 1). The particle may then be cleared out of the lung either through the 1306
mucociliary escalator (step 2) or through alveolar macrophage (AM) clearance (step 1307
3). If reactive, AM activation will follow with release of several factors and 1308
recruitment of other immune cells (AM and polymorphonucleate cells, PMN), 1309
eventual cell death and establishment of permanent cycles of ingestion (step 4). This 1310
process produces chronic inflammation (step 5). Combined with the direct action of 1311
the particle (step 6) this will cause damage to the target cells (epithelial, endothelial). 1312
If the particle is nano-sized, it may easily escape from the lung to the pleura and to 1313
systemic circulation (step 7). 1314
1315
Figure 3. The role of particle and cell derived free radicals and reactive oxygen 1316
species (ROS) in cell damage, oxidative stress and diseases 1317
1318
Figure 4. (a) Cumulative mass distribution of the grain size of selected Apollo soils, 1319
modified from Liu and Taylor (2011). (b) Comparison between number distributions 1320
of the grain size of the dust fraction of two Apollo samples and of the very fine 1321
fraction of lunar dust simulant JSC-1Avf, modified from Park et al. (2008). 1322
Figure 5. The effect of bond rupture following mechanical impact or cleavage in 1323
crystalline silica, adapted from Fubini et al. (2001). This mechanism can be 1324
extrapolated to silicates including lunar dust minerals and amorphous phases, 1325
provided most of the chemical bonds are covalent. 1326
1327
Figure 6. Total deposition of particles ranging in size from 0.5 to 3 μm in 1328
microgravity (panel A), 1 G (panel B) and 1.6 G (panel C). In each case the bars to the 1329
left of each pair (with error bars) are experimental data collected in humans. The bars 1330
to the right are the predictions based on standard models of aerosol deposition and 1331
include the effects of impaction (unshaded portion of the bar), sedimentation 1332
(diagonal shading), and diffusion (black filled portion). Reproduced from Darquenne 1333
et al. (1997) with permission. 1334
1335
Figure 7. Deposition of inhaled aerosol in 1 G (upper line) and in lunar gravity (1/6 1336
G) plotted as a function of volumetric depth in the airways to which the aerosol was 1337
inhaled. A penetration volume of 300 ml indicates deposition in the small to medium 1338
sized airways, while a penetration of volume of 1200 ml is within the alveoli. 1339
Although deposition is reduced in lunar gravity compared to that in 1 G, a given 1340
deposition fraction (say 25% as indicated by the dashed line) occurs much more 1341
peripherally in reduced gravity. Redrawn from Darquenne et al. (2008) with 1342
permission. 1343
1344
Figure 8. A schematic drawing of the Dustgun system for the exposures of the 1345
anaesthetised and tracheally intubated rat. PN, the pneumotachograph; DG, the 1346
DustGun aerosol generator; MF, the end filter; V, the vacuum pump; totalV& , the 1347
exposure airflow; ventV& , the ventilation airflow, generated by the spontaneously 1348
breathing animal; filterV& , the constant component of the exposure airflow. The balance 1349
of the airflow streams at the three-way junction is expressed as: 1350
0=++ filterventtotal VVV &&& . 1351
1352
Figure 9. UV light, particle radiation and mechanical disruption caused by 1353
micrometeoroid bombardment, individually or in combination, may alter the surface 1354
chemistry of lunar dust. Exposure to oxygen and water as well as other atmospheric 1355
gases is expected to cause passivation of the chemical reactivity of lunar dust. 1356
Figure 1 1357
1358
(a) 1359
1360
1361
(b) 1362
Num
ber o
fgra
ins
0
200
150
100
50
0 25 50 75Grain diameter (μm)
1363
Figure 2 1364
ClearanceClearance
Damage to target cells
2
Macrophageactivation
Endocytosis and tissue penetration
Cell death
Release of oxidants, cytokines, growth factorsrecruitment of AM and PMN
Direct action ontarget cells
Reactions withendogenous molecules
14
3
67
5
1365
Figure 3 1366
Membrane
Enzymes
DNA
Particle-derivedfree radicals
Cell-derivedfree radicals
Reactive Oxygen Species(ROS)
HO
H2O2O-
Loss of antioxidant defenses (ascorbic acid andglutathion) from the lung-lining layer
Oxidativestress
1367
1368
Figure 4 1369
Cum
ulat
ive
wt.%
pas
sing
thro
ugh
siev
e 100
110100100010,0000
20
40
60
80
Diameter (μm)
Apollo 12
Apollo 15
Apollo 17
a
b
Num
ber d
istr
ibut
ion
(arb
itrar
y sc
ale)
Apol
lo 1
7Apo
llo 1
1 JSC-1A vf
0.01 1010.1Diameter (μm)
1370
Figure 5 1371
Homolytic cleavage of the Si-O bond
Heterolytic cleavage of the Si-O bond
Si Si
O
Si Si
O
Si Si
O
Si+
Si
O
-
Dangling bonds
Surface charges
1372
Figure 6 1373
1374
Figure 7 1375
1376
Figure 8 1377
1378
Figure 9 1379
UV light
Mechanical Disruption
Particle Radiation?
Alteration ofsurface chemistry
Lunar dustparticles
Chemically reactiveLunar dust
Passivation
Reduced chemical Reactivity
Oxygen Water
Table 1. Knowledge gaps related to physical and chemical properties of dust in relation to potential toxicity 1380
Number
Topic
Suspected relevance to dust toxicity
Current state of knowledge for lunar dust
Priority for lunar dust related measurements
Type of studies required
1 Activation of lunar dust due to proton radiation, galactic cosmic radiation, solar particle events, ultraviolet radiation, solar wind implantation, and micrometeoroid impact fragmentation
High Unknown High Ground-based; In situ
2 Identification and evaluation of surface-derived free radical generation pathways
Very high Limited to some ground-based studies of lunar samples
Critical Ground-based; In situ
3 Passivation mechanism and rate after exposure of reactive lunar dust to habitat-like atmospheres
High Unknown High Ground-based; In situ
4 Size distribution, specific surface area of the submicron size fraction
High Uncertain from measurements of lunar samples
High Ground-based; In situ
5 Size fraction variations of nanophase iron abundance Very high if it becomes exposed
Abundance known for selected sites and size fractions
High Ground-based; In situ
6 Efficiency of release of nanophase iron from glassy matrix
High if very efficient
Limited High Ground-based
7 Overall mineralogy High Well-known for limited number of sites, rough estimates available from remote sensing
Medium In situ
Number
Topic
Suspected relevance to dust toxicity
Current state of knowledge for lunar dust
Priority for lunar dust related measurements
Type of studies required
8 Other physical properties of the smallest size fraction (morphology, dielectric constant, crystallinity)
Medium Poorly known Medium Ground-based; In situ
9 Abundance of volatile components on the lunar surface
Possibly high Significant uncertainties, particularly for high latitudes
Unknown Ground-based on pristine Apollo samples; In situ
10 Aerosol generation from lunar dust during typical mission activities
High Medium from Apollo missions
Medium In situ
1381
Table 2: Knowledge gaps related to physiology and adverse health effects 1382
Number
Topic
Suspected relevance to dust toxicity
Current state of knowledge for lunar dust
Priority for lunar dust related measurements
Type of studies required
11 Relation between surface active sites including those generated by radiation and micrometeoroid impact effects and adverse health effects
Very high Unknown Critical Ground-based
12 Toxicity of nanophase iron Very high Unknown High Ground-based 13 Toxicity of ilmenite Low Unknown Low Ground-based 14 Dust deposition in sustained low gravity Medium Deposition in